Skip to main content

Featured Editorial

Shifts at The Helm: gratitude, re-commitment to our work, and a call for addictions disparities research
Emily C. Williams & Jeffrey H. Samet, Editors-in-Chief
The work of our ASCP community has never been more relevant. Though addiction is a consistent and ubiquitous threat to public health across cultures and societies globally, roughly over the same period as our journal was gaining momentum, substance use reached an all-time high. The field is ripe for new and innovative studies focused on understanding disparities and their structural origins; development of new and innovative clinical practices to address old and emerging challenges in addictions treatment; and rigorous evaluations of policies ushered in as a result of the global pandemic that has disproportionately influenced vulnerable and historically stigmatized populations.

Lessons Learned from the Grayken Clinical Addiction Case Conference

Grayken Lessons are a series of case reports originating from the clinical experience of addiction fellows at the Grayken Center for Addiction at Boston Medical Center, as well as from some other academic institutions. Interactive round table discussions explore specific cases presented by fellows with key lessons learnt presented here.

Read More

Aims and scope

Addiction Science & Clinical Practice provides a forum for clinically relevant research and perspectives that contribute to improving the quality of care for people with unhealthy alcohol, tobacco, or other drug use and addictive behaviours across a spectrum of clinical settings.

Articles

Pre-exposure Prophylaxis for People Who Use Drugs

Guest Editors:
Angela Bazzi: University of California, United States
Tyler Bartholomew:  University of Miami, United States
Hansel Tookes: University of Miami, United States

Recent collection: Substance use in rural communities

Read through our collection addressing the quality of care for people using drugs and alcohol in rural communities, models for improving access to substance use disorder screening and treatment, and interactions between harm reduction and substance use treatment services, as well as impacts from the COVID-19 pandemic.

Trending articles

Click here to see recent articles that are trending in Addiction Science & Clinical Practice, including news, policy and more!

Editors profiles

Dr Jeffrey Samet, co-Editor-in-Chief

"Improving the quality of care provided to patients with problems from the use of alcohol and other drugs should be a major health-care goal and research agenda as articulated in the 2006 US Institute of Medicine report, Improving the Quality of Health Care for Mental and Substance Use Conditions. Our goal is to make Addiction Science & Clinical Practice the primary home for evidence to address this international health-care challenge."

Dr Emily C Williams, co-Editor-in-Chief

Addiction is a consistent and ubiquitous threat to public health across cultures and societies globally, and the work of Addiction Science & Clinical Practice has never been more relevant as substance use has reached an all-time high, innovative clinical interventions are increasingly available, and social determinants of substance use and its care receive increasing focus.  I am excited to move the work of Addiction Science & Clinical Practice forward, together with Dr Jeffrey Samet, and to contribute to providing a top-notch forum for clinically relevant research and perspectives that contribute to improving both the quality and equity of addictions care.”

Dr Emily Williams is an addictions health services and disparities researcher and an implementation scientist. She serves as Professor of Health Systems and Population Health and Director of the Doctoral Program in Health Services at the University of Washington. She also has affiliate appointments at the Denver-Seattle Center of Innovation for Veteran-Centered Value-Driven Care at VA Puget Sound Health Services Research & Development (HSR&D) and Kaiser Permanente Washington Health Research Institute. She is interested in the influence of contextual mechanisms on health behavior, health care, health outcomes, and health disparities, particularly with regard to vulnerable populations with stigmatized conditions. Her research focuses on increasing access to needed prevention and treatment for stigmatized conditions, including unhealthy alcohol, opioid, and other substance use, hepatitis C, HIV, as well as understanding and promoting equity in this care for vulnerable patient subpopulations (e.g., those with HIV and HCV, racial/ethnic minorities, persons living in rural areas, transgender patients, and women). She has a BA in political science from Lewis & Clark College (Portland, OR), an MPH in Health Law from Boston University (Boston, MA), and a PhD in Health Services from the University of Washington (Seattle, WA).

Society affiliation

International Network on Brief Interventions for Alcohol & Other Drugs

INEBRIA is an international network of researchers, policy makers, practitioners and other stakeholders interested in the potential of brief interventions in health and other settings to reduce the harms produced by alcohol and other drug use. Its main goals are:

1. To share information, experiences, research findings and expertise in the area of early identification and brief intervention for hazardous and harmful substance use.

2. To promote best practice in, and encourage the development of, guidelines for the wide dissemination and implementation of evidence-based early identification and brief intervention for hazardous and harmful substance use.

3. To identify gaps and needs for research in the field of early identification and brief intervention for hazardous and harmful substance use, promote International research co-operation and set standards for research.

4. To Promote the Integration of the study of brief interventions for hazardous and harmful substance use with the wider context of measures to prevent and reduce substance-related harm.

Addiction Science & Clinical Practice is an ISAJE Member Journal

Affiliated with

Annual Journal Metrics

  • 2022 Citation Impact
    3.7 - 2-year Impact Factor
    4.4 - 5-year Impact Factor
    0.956 - SNIP (Source Normalized Impact per Paper)
    1.166 - SJR (SCImago Journal Rank)

    2023 Speed
    25 days submission to first editorial decision for all manuscripts (Median)
    202 days submission to accept (Median)

    2023 Usage 
    755,413 downloads
    622 Altmetric mentions

Archival content

Addiction Science & Clinical Practice was formerly published by NIDA and previous issues of the journal can be viewed here.